Here's the article. Sweet. California Pacific Airlines

New Post Public Reply Private Reply Replies (2) Message Board
taketheredpill
842
Here's the article. Sweet.

California Pacific Airlines (Carlsbad, CA) has once more announced plans to start commercial passenger operations this time using an existing Part 121-certificated carrier.

In an interview with Oside News, the Carlsbad, CA-based start-up's Chief Commercial Officer Paul W. J. Hook said an unspecified "58-year-old airline" had been acquired with an official announcement due on November 16.

According to Hook, California Pacific Airlines aims to launch in April next year using an all-Embraer fleet of four ERJ-145s and two EMB-170s. Cities to be served include Phoenix Sky Harbor, Las Vegas McCarran, Sacramento Int'l, Oakland, San José, CA, and the Mexican resort town of San José Cabo.

“Each plane will have both first and business-class seating," he told Oside News. "Economy passengers won’t see much difference from business class. Our ticket pricing will be competitive with other airlines serving the area.”

The brainchild of nonagenarian entrepreneur Ted Vallas, California Pacific Airlines has undergone at least three unsuccessful attempts at acquiring an Air Carrier Certificate (ACC) from the US Federal Aviation Administration (FAA). The last attempt, in 2013, was suspended following an FAA manpower shortage brought on by budget cuts.

As such, the purchase of an existing airline replete with all the necessary permits and certificates is proving an increasingly popular shortcut to market among US-based start-ups. As recently reported, USGlobal Airways (formerly Baltia Air Lines) recently acquired Songbird Airways (SGB, Lakeland) in its own, separate bid to start commercial services.
3

Baltia Air Lines Inc (BLTA) Stock Research Links

BLTA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lumexa Imaging's Investor Conference Push: Any Real Substance?

Updated Category News Views 132

Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...

Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts

Updated Category News Views 173

Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...

Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms

Updated Category News Views 469

Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...

Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success

Updated Category News Views 197

Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...

Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration

Updated Category News Views 100

GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...

Continue Reading